![Pawel Jerzy Holstinghausen-Holsten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pawel Jerzy Holstinghausen-Holsten
Président chez
CAPTOR THERAPEUTICS SPOLKA AKCYJNA
Fortune : 12 M $ au 31/08/2026
Profil
Pawel Jerzy Holstinghausen-Holsten currently works at Captor Therapeutics SA, as Chairman-Supervisory Board from 2022 and Denovo Solutions Sp zoo, as Member-Management Board.
Mr. Holstinghausen-Holsten received his graduate degree from Warsaw School of Economics and graduate degree from the University of Warsaw.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/12/2025 | 600 954 ( 9,46% ) | 12 M $ | 31/08/2026 |
Postes actifs de Pawel Jerzy Holstinghausen-Holsten
| Sociétés | Poste | Début |
|---|---|---|
| CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Président | 30/06/2022 |
Denovo Solutions Sp zoo | Corporate Officer/Principal | - |
Formation de Pawel Jerzy Holstinghausen-Holsten
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Warsaw School of Economics
 Warsaw School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warsaw
 University of Warsaw Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Captor Therapeutics SA
 Captor Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company which develops protein degradation drugs for cancer and autoimmune diseases | Health Technology |
Denovo Solutions Sp zoo |
